Trial intelligence / Profile preview

Tanreqing oral liquid for acute bronchitis

ChiCTR2000040264Phase 3Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Nov 2020
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute bronchitis comparing Tanreqing group with Placebo group (2 arms). Primary endpoint: Cough resolution rate. Started Nov 2020; status: recruiting.

02

Drugs

tanreqing
03

Conditions

acute bronchitis

Beyond the preview

Go deeper on ChiCTR2000040264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call